Clinical trial
Pilot Study in Patients With Symptomatic Steroid-Naive Asthma
NCT00024544 · Facet Biotech, Industry · Completed
Key facts
| NCT number | NCT00024544 |
|---|---|
| Title | Pilot Study in Patients With Symptomatic Steroid-Naive Asthma |
| Official title | A Phase I/II, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Pilot Study of SB 240683 in Patients With Symptomatic Steroid-Naive Asthma |
| Lead sponsor | Facet Biotech, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | anti-IL-4 monoclonal antibody (pascolizumab) |
| Enrollment | 120 |
| Start date | Aug 1, 2001 |
| Primary completion | Feb 1, 2003 |
| Completion | Feb 1, 2003 |
| First posted | Sep 20, 2001 |
| Last update posted | Mar 7, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: